- Published at
- by insidermonkey.com
mixed
mixed
News for Regeneron Pharmaceuticals, Inc. (REGN)
- Published at
- by seekingalpha.com
neutralneutralRegeneron Pharmaceuticals, Inc. (REGN) Leerink Partners 2025 Global Healthcare Conference Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Leerink Partners 2025 Global Healthcare Conference Call March 11, 2025 8:00 AM ETCompany ParticipantsRyan...- Published at
- by insidermonkey.com
positivepositiveRegeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now
We recently compiled a list of the 11 Oversold Blue Chip Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.- Published at
- by gurufocus.com
negativenegativeREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals,- Published at
- by gurufocus.com
negativenegativeRegeneron Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 10, 2025 Deadline to file Lead Plaintiff Motion
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Fir- Published at
- by investopedia.com
mixedmixedS&P 500 Gains and Losses Today: Index Tumbles as Economic Concerns Intensify
The S&P 500 dropped 2.7% on Monday, March 10, as U.S. tariffs and government job cuts heightened economic uncertainty and provoked recession concerns.- Published at
- by gurufocus.com
negativenegativeDEADLINE ALERT for REGN and BIOA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of sha- Published at
- by gurufocus.com
neutralneutralREGN LAWSUIT ALERT: The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireNEW YORK, March 10, 2025 NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Ph- Published at
- by gurufocus.com
neutralneutralREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireLOS ANGELES, March 10, 2025 LOS ANGELES, March 10, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, remi- Published at
- by gurufocus.com
neutralneutralREGN Deadline: Rosen Law Firm Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Regeneron- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveRegeneron Pharmaceuticals Inc (REGN) Announces Promising Results for Dupixent in Treating Bullous Pemphigoid
Regeneron Pharmaceuticals Inc (REGN) and Sanofi have announced positive results from their ADEPT Phase 2/3 trial, evaluating Dupixent® (dupilumab) for treating- Published at
- by gurufocus.com
positivepositiveREGN Deadline: REGN Investors with Losses in Excess of $100K Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
PR NewswireNEW YORK, March 7, 2025 NEW YORK, March 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securit- Published at
- by gurufocus.com
negativenegativeDeadline Soon: Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
[url="]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming March 10, 2025 deadline to participate as a lead plaintiff in the securities fr- Published at
- by gurufocus.com
neutralneutralREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireLOS ANGELES, March 7, 2025 LOS ANGELES, March 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, remind- Published at
- by zacks.com
neutralneutralThe Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveREGN DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action -- REGN
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceu- Published at
- by seekingalpha.com
positivepositiveRegeneron Pharmaceuticals, Inc. (REGN) TD Cowen 45th Annual Health Care Conference (Transcript)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) TD Cowen 45th Annual Health Care Conference March 4, 2025 11:50 AM ETCompany ParticipantsMarion McCourt - EVP,...